The National Institute of Public Health (FHI) is asking Norwegians between the ages of 18 and 30 to participate in a study on the effect of vaccination against coronavirus.
The survey UngVoksen involves answering questionnaires, and some are asked to take a blood sample at Ullevål hospital, the FHI stated on Wednesday.
Participants will then receive an answer as to whether they have antibodies against coronavirus.
“It is very important to monitor the population’s resistance to coronavirus and whether the vaccines we use in Norway actually provide good protection.
“We hope that those who are invited to participate in UngVoksen will participate in this effort,” project manager Per Magnus at the FHI said.
Source: © NTB Scanpix / #Norway Today / #NorwayTodayNews
Do you have a news tip for Norway Today? We want to hear it. Get in touch at [email protected]
Be the first to comment on "FHI invites young adults to participate in vaccine study: “It’s very important”"